135054-67-0

Basic information

• Product Name: 2-Pyridinecarboxylic acid, 4-(chlorocarbonyl)-, methyl ester (9CI)
• Synonyms: 2-Pyridinecarboxylic acid, 4-(chlorocarbonyl)-, methyl ester (9CI)
• CAS NO: 135054-67-0
• Molecular Formula: C8H6ClNO3
• Molecular Weight: 199.59114
• Product Categories: ACIDHALIDE
• Mol File: 135054-67-0.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 327.6±27.0 °C(Predicted)
• Appearance: /
• Density: 1.358±0.06 g/cm3(Predicted)
• PKA: -1.86±0.10(Predicted)
• CAS DataBase Reference: 2-Pyridinecarboxylic acid, 4-(chlorocarbonyl)-, methyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinecarboxylic acid, 4-(chlorocarbonyl)-, methyl ester (9CI)(135054-67-0)
• EPA Substance Registry System: 2-Pyridinecarboxylic acid, 4-(chlorocarbonyl)-, methyl ester (9CI)(135054-67-0)

Safety Data

• Hazardous Substances Data: 135054-67-0(Hazardous Substances Data)

Upstream product

• 24195-10-6 pyridine-2,4-dicarboxylic acid 2-methyl ester 

Relevant articles and documents

FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES

The present invention discloses compounds according to Formula I: Wherein A, B, R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, pain, and/or abnormal angiogenesis associated diseases by administering the compounds of the invention.